Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
1
|
| pubmed:dateCreated |
1984-6-14
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0048-5764
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
20
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
103-7
|
| pubmed:dateRevised |
2009-11-11
|
| pubmed:meshHeading |
pubmed-meshheading:6718635-Adult,
pubmed-meshheading:6718635-Apomorphine,
pubmed-meshheading:6718635-Dyskinesia, Drug-Induced,
pubmed-meshheading:6718635-Homovanillic Acid,
pubmed-meshheading:6718635-Hormones,
pubmed-meshheading:6718635-Humans,
pubmed-meshheading:6718635-Male,
pubmed-meshheading:6718635-Middle Aged,
pubmed-meshheading:6718635-Schizophrenia
|
| pubmed:year |
1984
|
| pubmed:articleTitle |
Apomorphine and schizophrenia.
|
| pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, Non-P.H.S.,
Randomized Controlled Trial
|